特立帕肽（CAS 52232-67-4）：分子式 C181H291N55O51S2、分子量 4118。
| CAS号 | 52232-67-4 |
|---|---|
| 分子式 | C181H291N55O51S2 |
| 分子量 | 4118 |
| LogP | -18.7 |
| 应用领域 | Uses: Stimulates new bone formation on trabecular and cortical (periosteal and、or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.、Bone Density Conservation Agents、Methods of Manufacturing: Manufactured using a strain of Escherichia coli modified by recombinant DNA technology、Formulations、Preparations: Parenteral: Injection: 750 ug、3 mL (20 ug per metered dose、pen device)、Forteo (available as prefilled disposable cartridge)、(Lilly). |
登记用途：Uses: Stimulates new bone formation on trabecular and cortical (periosteal and、or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.、Bone Density Conservation Agents、Methods of Manufacturing: Manufactured using a strain of Escherichia coli modified by recombinant DNA technology、Formulations、Preparations: Parenteral: Injection: 750 ug、3 mL (20 ug per metered dose、pen device)、Forteo (available as prefilled disposable cartridge)、(Lilly).。
特立帕肽 是一种化工化合物，登记 CAS 号为 52232-67-4，分子式 C181H291N55O51S2（分子量 4118）。
登记 CAS 号：52232-67-4
其分子式 C181H291N55O51S2 由 181 个碳、291 个氢、55 个氮、51 个氧、2 个硫 组成。
别名/同义词：特立帕肽 · Teriparatide
特立帕肽 的 CAS 登记号为 52232-67-4。
分子式 C181H291N55O51S2，分子量 4118。
别名/同义词：特立帕肽、Teriparatide。
登记用途：Uses: Stimulates new bone formation on trabecular and cortical (periosteal and、or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.、Bone Density Conservation Agents、Methods of Manufacturing: Manufactured using a strain of Escherichia coli modified by recombinant DNA technology、Formulations、Preparations: Parenteral: Injection: 750 ug、3 mL (20 ug per metered dose、pen device)、Forteo (available as prefilled disposable cartridge)、(Lilly).。
特立帕肽（CAS 52232-67-4）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 52232-67-4 |
|---|---|
| PubChem CID | 16133850 |
| Molecular formula | C181H291N55O51S2 |
| UNII (FDA) | 10T9CSU89I |
| Molecular Weight | 4118 |
|---|---|
| XLogP3 | -18.7 |
| Hydrogen Bond Donor Count | 60 |
| Hydrogen Bond Acceptor Count | 62 |
| Rotatable Bond Count | 146 |
| Exact Mass | 4116.1342973 |
| Monoisotopic Mass | 4115.1309424 |
| Topological Polar Surface Area | 1800 |
| Heavy Atom Count | 289 |
TERIPARATIDE; 52232-67-4; Teriparatida; Teriparatidum; 1-34-Human PTH; Human PTH (1-34); ZT-034; LY 333334; 10T9CSU89I; TERIPARATIDE RECOMBINANT HUMAN; hPTH (1-34); BONSITY; RefChem:56774; H05AA02; DTXSID001027900; Teriparatide (genetical recombination)
| Reported hazard statements | H302 (16.7%), H332 (16.7%), H351 (50%), H361 (100%), H372 (33.3%), H373 (16.7%), H336, H350 |
|---|
H302 (16.7%): Harmful if swallowed [Warning Acute toxicity, oral]
H332 (16.7%): Harmful if inhaled [Warning Acute toxicity, inhalation]
Teriparatide · CAS 52232-67-4 · C181H291N55O51S2. UNII 10T9CSU89I.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Teriparatide